These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 38164241)

  • 1. Rapid predictive dosimetry for Second Strike prescription based on whole body radioiodine kinetics in differentiated thyroid cancer.
    Kao YH
    Asia Ocean J Nucl Med Biol; 2024; 12(1):37-42. PubMed ID: 38164241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. First Strike personalized predictive radioiodine prescription for inoperable metastatic differentiated thyroid cancer.
    Kao YH
    Asia Ocean J Nucl Med Biol; 2023; 11(2):158-167. PubMed ID: 37324232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lung dosimetry for radioiodine treatment planning in the case of diffuse lung metastases.
    Song H; He B; Prideaux A; Du Y; Frey E; Kasecamp W; Ladenson PW; Wahl RL; Sgouros G
    J Nucl Med; 2006 Dec; 47(12):1985-94. PubMed ID: 17138741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid predictive dosimetry for radioembolization.
    Kao YH
    Asia Ocean J Nucl Med Biol; 2024; 12(1):35-36. PubMed ID: 38164237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Red Marrow Absorbed Dose Calculation in Thyroid Cancer Patient Using a Simplified Excel Spreadsheet.
    Songprakhon R; Roysri K; Charoenphun P; Chuamsaamarkkee K
    Mol Imaging Radionucl Ther; 2020 Oct; 29(3):124-131. PubMed ID: 33094576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ten Year Experience of Radioiodine Dosimetry: is it Useful in the Management of Metastatic Differentiated Thyroid Cancer?
    Sun F; Gerrard GE; Roberts JK; Telford T; Namini S; Waller M; Flux G; Gill VM
    Clin Oncol (R Coll Radiol); 2017 May; 29(5):310-315. PubMed ID: 28132755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Red marrow and blood dosimetry in (131)I treatment of metastatic thyroid carcinoma: pre-treatment versus in-therapy results.
    Giostra A; Richetta E; Pasquino M; Miranti A; Cutaia C; Brusasco G; Pellerito RE; Stasi M
    Phys Med Biol; 2016 Jun; 61(11):4316-26. PubMed ID: 27200493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation of post-therapeutic image-based thyroid dosimetry using quantitative SPECT/CT, iodine biokinetics, and the MIRD's voxel S values in Graves' disease.
    Fujita N; Koshiba Y; Abe S; Kato K
    EJNMMI Phys; 2020 Jan; 7(1):6. PubMed ID: 31993828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A simplified general schema for rapid single time-point marrow predictive dosimetry.
    Kao YH
    Nucl Med Commun; 2023 Dec; 44(12):1187-1188. PubMed ID: 37706257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant Human Thyroid-Stimulating Hormone Versus Thyroid Hormone Withdrawal in
    Plyku D; Hobbs RF; Huang K; Atkins F; Garcia C; Sgouros G; Van Nostrand D
    J Nucl Med; 2017 Jul; 58(7):1146-1154. PubMed ID: 28104741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone marrow dosimetry and safety of high 131I activities given after recombinant human thyroid-stimulating hormone to treat metastatic differentiated thyroid cancer.
    de Keizer B; Hoekstra A; Konijnenberg MW; de Vos F; Lambert B; van Rijk PP; Lips CJ; de Klerk JM
    J Nucl Med; 2004 Sep; 45(9):1549-54. PubMed ID: 15347723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Whole-remnant and maximum-voxel SPECT/CT dosimetry in
    Mínguez P; Flux G; Genollá J; Delgado A; Rodeño E; Sjögreen Gleisner K
    Med Phys; 2016 Oct; 43(10):5279-5287. PubMed ID: 28105713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Indirect assessment of the maximum empirical activity (250 mCi) with respect to dosimetry concepts in radioiodine therapy of metastatic differentiated thyroid cancer.
    Abuqbeitah M; Demir M; Kabasakal L; Çavdar İ; Uslu-Beşli L; Yeyin N; Razavikhosroshahi S; Sönmezoğlu K
    Nucl Med Commun; 2018 Nov; 39(11):969-975. PubMed ID: 30180046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood dosimetry from a single measurement of the whole body radioiodine retention in patients with differentiated thyroid carcinoma.
    Hänscheid H; Lassmann M; Luster M; Kloos RT; Reiners C
    Endocr Relat Cancer; 2009 Dec; 16(4):1283-9. PubMed ID: 19628649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lung toxicity in radioiodine therapy of thyroid carcinoma: development of a dose-rate method and dosimetric implications of the 80-mCi rule.
    Sgouros G; Song H; Ladenson PW; Wahl RL
    J Nucl Med; 2006 Dec; 47(12):1977-84. PubMed ID: 17138740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does radioiodine therapy have disadvantageous effects in non-iodine accumulating differentiated thyroid carcinoma?
    Schaap J; Eustatia-Rutten CF; Stokkel M; Links TP; Diamant M; van der Velde EA; Romijn JA; Smit JW
    Clin Endocrinol (Oxf); 2002 Jul; 57(1):117-24. PubMed ID: 12100079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improving individualised dosimetry in radioiodine therapy for hyperthyroidism using population biokinetic modelling.
    Melgar Pérez J; Orellana Salas A; Santaella Guardiola Y; Antoranz Callejo JC
    Phys Med; 2019 Jun; 62():33-40. PubMed ID: 31153396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Iodine kinetics and dosimetry in the salivary glands during repeated courses of radioiodine therapy for thyroid cancer.
    Liu B; Huang R; Kuang A; Zhao Z; Zeng Y; Wang J; Tian R
    Med Phys; 2011 Oct; 38(10):5412-9. PubMed ID: 21992360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient dosimetry in radionuclide therapy: the whys and the wherefores.
    Thierens HM; Monsieurs MA; Bacher K
    Nucl Med Commun; 2005 Jul; 26(7):593-9. PubMed ID: 15942479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Individualized dosimetry in the management of metastatic differentiated thyroid cancer.
    Chiesa C; Castellani MR; Vellani C; Orunesu E; Negri A; Azzeroni R; Botta F; Maccauro M; Aliberti G; Seregni E; Lassmann M; Bombardieri E
    Q J Nucl Med Mol Imaging; 2009 Oct; 53(5):546-61. PubMed ID: 19910908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.